ArticleBreast cancer research and treatment2026
Equivalent survival in targeted axillary dissection compared to axillary lymph node dissection in patients with node positive breast cancer receiving neoadjuvant chemotherapy.
Callie Hlavin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.